← Leaderboard
INCY
Ticker
INCY
Congressional Trades
13
by 2 members
Ticker Intelligence Brief
Who in Congress traded INCY, when, and what happened after?
A ticker-first view for retail/data users: latest disclosure, largest range, disclosure lag, party flow, contracts, lobbying, and source-linked receipts.
Latest receipt
Ro Khanna
BUY · 2026-05-15
Largest range
$1K – $15K
Ro Khanna
Slowest filing
35d
Ro Khanna
Best vs SPY
46.6%
Ro Khanna
Buys
8
62%
Sells
5
38%
Total Volume
$104K
midpoint
Unique Traders
2
members
Party Breakdown
Democrats11 · 85%
Republicans2 · 15%
Party Trading Divergence
Democrat vs. Republican buy / sell pressure by monthHIGH DIVERGENCEBar length = total trades. Color = net sentiment — green = net buying, red = net selling. Months with no activity hidden.
Democrat ←
Month
→ Republican
1▲
Mar '24
—
0▲1▼
Apr '24
—
1▲
Aug '24
—
1▲
Nov '24
—
1▲
Jan '25
—
0▲1▼
Feb '25
—
1▲
May '25⚡
0▲2▼
1▲
Jan '26
—
1▲1▼
Mar '26
—
1▲
May '26
—
Democrats8▲3▼Net buyers
vs
Republicans0▲2▼Net sellers
Net buyingNet selling⚡ Party split
🏛️ Federal Contracts
all →- 2026-03-27$500KDepartment of Veterans AffairsPATHOLOGY LAB SERVICES.
💼 Lobbying Filings
all →- 2026-04-20$480KINCYTE CORPORATIONH.R. 946 / S. 1862, Orphan Cures Act implementation H.R. 1262 Give Kids a Chance Act Issues related to Medicaid rebates Issues related to implementation of the Inflation Reduction Act Issues related to the 340B Drug Pricing Program Issues related to drug cost and pricing Education around access to innovative therapies in dermatology
- 2026-04-20$60KINCYTE CORPORATIONIssues related to 340b; Public Law No: 119-75, Consolidated Appropriations Act, 2026 - issues related to expiring healthcare extenders and expiring Advanced Premium Tax Credits (APTC) Issues related to Medicaid rebates; Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to CMMI demos (Guarding U.S. Medicare Against Rising Drug Costs (GUARD) and Global Benchmark for Efficient Drug Pricing (GLOBE))
- 2026-04-18$80KINCYTE CORPORATIONIssues related to Medicare Part D and Part B Pricing Reform; Issues related to Medicaid Rebates; Issues related to H.R. 946/S. 1862 - ORPHAN Cures Act.
- 2026-04-18$60KINCYTE CORPORATIONEducation around access to innovative therapies in dermatology. Issues related to Medicaid Drug Rebate program rule. Public Law 119-21: One Big Beautiful Bill Act, as it relates to H.R.946 - ORPHAN Cures Act. Issues related to drug pricing.
- 2026-04-17$110KINCYTE CORPORATIONIssues relating to CMS coverage and reimbursement policies.
- 2026-04-17$50KINCYTE CORPORATIONHealthcare-related legislative and regulatory issues impacting the biotechnology, pharmaceutical, and consumer health industry. Healthcare-related legislative and regulatory issues impacting the biotechnology, pharmaceutical, and consumer health industry.
- 2026-01-20$530KINCYTE CORPORATIONH.R. 946/S. 1862, Orphan Cures Act implementation H.R. 1262 Give Kids a Chance Act Issues related to Medicaid rebates Issues related to Medicaid coverage of new drugs Issues related to implementation of the Inflation Reduction Act Issues related to the 340B Drug Pricing Program Issues related to drug cost and pricing Education around access to innovative therapies in dermatology
- 2026-01-20$80KINCYTE CORPORATIONIssues related to Medicare Part D and Part B Pricing Reform; Issues related to Medicaid Rebates; Issues related to H.R. 946/S. 1862 - ORPHAN Cures Act.
- 2026-01-20$70KINCYTE CORPORATIONIssues relating to CMS coverage and reimbursement policies.
- 2026-01-20$60KINCYTE CORPORATIONEducation around access to innovative therapies in dermatology. Issues related to the 340(b)program. Issues related to Medicaid Drug Rebate program rule. Public Law 119-21: One Big Beautiful Bill Act, as it relates to H.R.946 - ORPHAN Cures Act.
Congressional Momentum
buy vs. sell pressureACCUMULATINGScore 0–100: above 50 = net buying pressure, below 50 = net selling. Signal based on last 90 days.
Last 30 Days
No trades
Last 90 Days
▲100
2 buys2 total0 sells
$16K buys · $0 sells
All-Time
▲62
8 buys13 total5 sells
$64K buys · $40K sells
Cumulative Net Position (buy vol − sell vol)
+$24K
2024-0313 trades plotted2026-05
Timing Fingerprint
filing delay vs. excess return over SPY · 12 tradesCongress avg +15.8% vs SPYEach dot = one disclosed trade. X-axis = days between trade and STOCK Act filing.Y-axis = return above (or below) SPY over the subsequent holding window. Upper-right = late filers who beat the market.
75% of trades beat SPYavg excess +15.8%avg delay 18d8 buys4 sellsBuySellOther· dot size ∝ trade size
Trade Activity Timeline
Congressional buys & sells by month · last 10 months w/ activity
24/03
24/04
24/08
24/11
25/01
25/02
25/05
26/01
26/03
26/05
BuysSellsOtherHigh-volume month
Who Moved First
each row = one member · sorted by earliest disclosed trade1 buyers ·2 sellers
BuySellOtherDot size ∝ trade size · top 2 most-active traders shown
Seasonal Rhythm
Congress buy/sell pressure by month & yearEach cell = one calendar month. Green = net Congress buying, red = net selling. Intensity ∝ consensus strength. Hover for details.
Net buyingNet sellingNo trades · number = trade count
Peak buy month: Jan · Peak sell month: May
Congressional Conviction Timeline
net positioning · alpha track recordBULLISH8 buys5 sellscumulative α +93.3%10mo tracked
Monthly Net Flow (Buys − Sells)
Cumulative Excess Return on Congressional Buys vs SPY
All Disclosed Trades
| Date | Member | Action | Amount | Filing Delay | Receipt |
|---|---|---|---|---|---|
| 2026-05-15 | DRo Khanna | BUY | $1K – $15K | 25d | receipt → |
| 2026-03-30 | DRo Khanna | BUY | $1K – $15K | 8d | receipt → |
| 2026-03-10 | DRo Khanna | SELL | $1K – $15K | 28d | receipt → |
| 2026-01-29 | DRo Khanna | BUY | $1K – $15K | 8d | receipt → |
| 2025-05-19 | DRo Khanna | BUY | $1K – $15K | 22d | receipt → |
| 2025-05-15 | RRobert Bresnahan | SELL | $1K – $15K | 18d | receipt → |
| 2025-05-15 | RRobert Bresnahan | SELL | $1K – $15K | 16d | receipt → |
| 2025-02-19 | DRo Khanna | SELL | $1K – $15K | 15d | receipt → |
| 2025-01-17 | DRo Khanna | BUY | $1K – $15K | 20d | receipt → |
| 2024-11-15 | DRo Khanna | BUY | $1K – $15K | 20d | receipt → |
| 2024-08-02 | DRo Khanna | BUY | $1K – $15K | 35d | receipt → |
| 2024-04-23 | DRo Khanna | SELL | $1K – $15K | 13d | receipt → |
| 2024-03-25 | DRo Khanna | BUY | $1K – $15K | 11d | receipt → |